NCT02132845View on ClinicalTrials.gov

Next Generation Sequence Target-Directed Therapy in Treating Patients With Cancer

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 17, 2016

Primary Completion Date

May 10, 2018

Study Completion Date

May 10, 2018

Conditions
Malignant Neoplasm
Interventions
OTHER

cytology specimen collection procedure

Undergo collection of tissue and blood samples

DRUG

targeted therapy

Receive target-directed therapy

PROCEDURE

therapeutic procedure

Receive standard of care therapy

OTHER

laboratory biomarker analysis

Correlative studies

Trial Locations (1)

19111

Fox Chase Cancer Center, Philadelphia

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Fox Chase Cancer Center

OTHER

NCT02132845 - Next Generation Sequence Target-Directed Therapy in Treating Patients With Cancer | Biotech Hunter | Biotech Hunter